Miklós Mózes

850 total citations
23 papers, 697 citations indexed

About

Miklós Mózes is a scholar working on Molecular Biology, Nephrology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Miklós Mózes has authored 23 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Nephrology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Miklós Mózes's work include Renal and related cancers (5 papers), Chronic Kidney Disease and Diabetes (5 papers) and TGF-β signaling in diseases (4 papers). Miklós Mózes is often cited by papers focused on Renal and related cancers (5 papers), Chronic Kidney Disease and Diabetes (5 papers) and TGF-β signaling in diseases (4 papers). Miklós Mózes collaborates with scholars based in Hungary, Germany and United States. Miklós Mózes's co-authors include Gábor Kökény, Georg Hansmann, Laurent Calvier, Jeffrey B. Kopp, Ekaterina Legchenko, Philippe Chouvarine, Terry A. Jacot, Erwin P. Böttinger, László Rosivall and Danny Jonigk and has published in prestigious journals such as PLoS ONE, Cell Metabolism and International Journal of Molecular Sciences.

In The Last Decade

Miklós Mózes

22 papers receiving 688 citations

Peers

Miklós Mózes
Comparison fields: 5 of 91
  • Molecular Biology 303
  • Pulmonary and Respiratory Medicine 164
  • Nephrology 132
  • Cardiology and Cardiovascular Medicine 119
  • Surgery 88
Ana M. Blázquez‐Medela United States
Lucie Hénaut France
Miguel Carracedo Sweden
Lian Xu China
Stephen M. Twigg Australia
Timothy Tolley United States
Hairuo Lin China
Ming-Hui Zheng China
Jun Lei United States
Toshinori Ueno Japan
Ana M. Blázquez‐Medela United States View profile →
Citations per field, relative to Miklós Mózes
Miklós Mózes · 1×
Citations per year, relative to Miklós Mózes
Miklós Mózes · 1×

Countries citing papers authored by Miklós Mózes

Since Specialization
Citations

This map shows the geographic impact of Miklós Mózes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miklós Mózes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miklós Mózes more than expected).

Fields of papers citing papers by Miklós Mózes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miklós Mózes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miklós Mózes. The network helps show where Miklós Mózes may publish in the future.

Co-authorship network of co-authors of Miklós Mózes

This figure shows the co-authorship network connecting the top 25 collaborators of Miklós Mózes. A scholar is included among the top collaborators of Miklós Mózes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miklós Mózes. Miklós Mózes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Effects of in vivo chlorobenzene exposure on bone tissue in a rat model Biologia Futura Béla Hegedüs, Miklós Mózes et al. 0
2 Study of endocrine disruptor effects in AVP and OT mediated behavioral and reproductive processes in female rat models Physiology & Behavior Anna László, Márta Gálfi et al. 1
3 Renal Epithelial Complement C3 Expression Affects Kidney Fibrosis Progression International Journal of Molecular Sciences Miklós Mózes, Gábor Kökény et al. 1
4 Pioglitazone Protects Tubular Epithelial Cells during Kidney Fibrosis by Attenuating miRNA Dysregulation and Autophagy Dysfunction Induced by TGF-β International Journal of Molecular Sciences Miklós Mózes, Georg Hansmann et al. 3
5 Susceptibility to kidney fibrosis in mice is associated with early growth response-2 protein and tissue inhibitor of metalloproteinase-1 expression Kidney International Gábor Kökény, Jeffrey B. Kopp et al. 21
6 Chronic TGF-β1 Signaling in Pulmonary Arterial Hypertension Induces Sustained Canonical Smad3 Pathways in Vascular Smooth Muscle Cells American Journal of Respiratory Cell and Molecular Biology Laurent Calvier, Philippe Chouvarine et al. 16
7 PPARγ is a gatekeeper for extracellular matrix and vascular cell homeostasis Current Opinion in Nephrology & Hypertension Gábor Kökény, Laurent Calvier et al. 45
8 Cell physiological effects of glass ionomer cements on fibroblast cells Toxicology in Vitro Orsolya Láng, László Kőhidai et al. 15
9 The PPARγ agonist pioglitazone prevents TGF-β induced renal fibrosis by repressing EGR-1 and STAT3 BMC Nephrology Miklós Mózes, Laurent Calvier et al. 55
10 Alterations in SCAI Expression during Cell Plasticity, Fibrosis and Cancer Pathology & Oncology Research Ákos Gasparics, Gábor Kökény et al. 11
11 PPARγ Links BMP2 and TGFβ1 Pathways in Vascular Smooth Muscle Cells, Regulating Cell Proliferation and Glucose Metabolism Cell Metabolism Laurent Calvier, Philippe Chouvarine et al. 189
12 The Effect of Combined Treatment with the (Pro)Renin Receptor Blocker HRP and Quinapril in Type 1 Diabetic Rats Kidney & Blood Pressure Research Gábor Kökény, Csaba Révész et al. 9
13 Sustained hyperosmolarity increses TGF-ß1 and Egr-1 expression in the rat renal medulla BMC Nephrology Miklós Mózes, Petra Szoleczky et al. 9
14 LPS-Induced Delayed Preconditioning Is Mediated by Hsp90 and Involves the Heat Shock Response in Mouse Kidney PLoS ONE Tamás Kaucsár, Csaba Bödör et al. 8
15 Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3′,5′ guanosine monophosphate (cGMP) level in podocytes Nephrology Dialysis Transplantation Tamás Radovits, Gábor Szabó et al. 55
16 Characterization and Role of SCAI during Renal Fibrosis and Epithelial-to-Mesenchymal Transition American Journal Of Pathology Attila Fintha, Ákos Gasparics et al. 28
17 Increased renoprotection with ACE inhibitor plus aldosterone antagonist as compared to monotherapies—the effect on podocytes Nephrology Dialysis Transplantation Gábor Kökény, Mária Godó et al. 18
18 OVEREXPRESSION OF THE TYPE II TRANSFORMING GROWTH FACTOR‐β RECEPTOR INHIBITS FIBROBLAST PROLIFERATION AND ACTIVATES EXTRACELLULAR SIGNAL REGULATED KINASE AND C‐JUN N‐TERMINAL KINASE Cell Biology International Howard Goldberg, Tamás Húszár et al. 14
19 Renal Expression of Fibrotic Matrix Proteins and of Transforming Growth Factor-β (TGF-β) Isoforms in TGF-β Transgenic Mice Journal of the American Society of Nephrology Miklós Mózes, Erwin P. Böttinger et al. 120
20 Isoform specificity of commercially-available anti-TGF-β antibodies Journal of Immunological Methods Miklós Mózes, Timea Hodics et al. 9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026